NovaBay Pharmaceuticals Inc. (NBY) shares were rising 15.25% to trade at $0.34 in pre-market at last check. NovaBay (NBY) stock gained 0.68% to close Thursday’s session at $0.295. The stock volume remained 0.62 million shares, which was lower than the average daily volume of 0.98 million shares within the past 50 days. NBY shares have […]
Do NovaBay (NBY) Fit In A Value Investing Philosophy? Read More »
Kintara Therapeutics, Inc. (KTRA) has seen decrease of 1.13% in the premarket despite any news reported by the company. However, the last trading session closed at $0.354 with a decrease of 10.27%. Multiyear Research Grant – What’s up? KTRA announced on 12th January 2022 that Doctor Anna Golebiewska has been awarded with a multiyear research
Kintara Therapeutics, Inc. (KTRA) stock is going down – Learn more about it! Read More »
Orgenesis Inc. (NASDAQ: ORGS) is 0.35% higher on its value in year-to-date trading and has touched a low of $2.12 and a high of $8.30 in the current 52-week trading range. The Orgenesis (ORGS) stock was last observed hovering at around $2.89 in the last trading session, with the day’s gain setting it 12.45% off
Orgenesis (ORGS) Testing Investors’ Patience Right Now Read More »
Bluejay Diagnostics, Inc. (BJDX) has seen a push of 9.03% in the premarket despite any latest news. However, the last trading session closed at $1.55 with a decrease of 8.28%. Completion of 90 Subjects in Multicenter Clinical Study BJDX announced on 13th January 2022 that in a randomized multicenter clinical trial targeting the fast IL-6
Bluejay Diagnostics, Inc. (BJDX) Increases 9.03% in Premarket – Here’s What To Know Read More »
Imperial Petroleum Inc. (IMPP) stock leaped by a huge 53.45% in the premarket, at the last check on Friday after a Form F-1/A filing with the Securities Exchange Commission (SEC). In the previous trading session, IMPP remained gloomy with a loss of 10.77% at its close of $1.16. Following the SEC filing, the stock was
Imperial Petroleum Inc. (IMPP) Stock Outperforms in Premarket Following an SEC Filing Read More »
Clearfield, Inc. (CLFD) experienced an increase of 11.41% in the premarket because the company reported Fiscal First Quarter 2022 Results. However, the last trading session concluded at $48.65 with a decrease of 3.15%. Fiscal First Quarter 2022 Results by CLFD CLFD announced Fiscal First Quarter 2022 Results on 27th January 2022. The company recorded
Clearfield, Inc. (CLFD) stock is jumping to 11.41% in premarket – What’s influencing it? Read More »
Everspin Technologies, Inc. (MRAM) has seen a push of 13.41% in the premarket despite any official news released by the company. However, the last trading session closed at $7.98 with a decrease of 5.45%. Semi Americas Award – More About it MRAM announced on 8th December 2021 that it has been granted the 2021 SEMI
On January 27, Zynerba Pharmaceuticals Inc. (ZYNE) stock suffered a further loss of 5.83% in the pre-market. There has been no recent announcement from the company. In the prior trading session, the stock remained gloomy with a slight loss of 0.41% at $2.40. This decline escalated in the pre market, making the stock go down
Zynerba Pharmaceuticals Inc. (ZYNE) Stock Falls Deep Pre Market. Any Reason? Read More »
Shares of LSI Industries Inc (LYTS) have gained 17.83% during the trading session on Thursday, reaching a low of $6.52 while touching a high of $7.2157. During the trading session, a total of 0.22 million LYTS shares were traded which represents a 313.1% incline from the average session volume which is 54.14K shares. LSI Industries
Reviewing The Case For LSI Industries (LYTS) Going Higher Read More »
On January 27, Trevena Inc. (TRVN) declared the acceptance of NDA submission for oliceridine injection by China NMPA. Following the announcement, the stock became bullish in the premarket trading on Friday. During regular trading, the stock fluctuated between a high of $0.5600 and a low of $0.4630. TRVN closed the session at $0.4800, with a
Trevena Inc. (TRVN) Stock Bullish in Pre Market Following an Upbeat News Read More »
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.